Clinical utility of comprehensive genomic profiling tests for advanced or metastatic solid tumor in clinical practice

Previous clinical trials indicate that 10%–25% of patients received genomically matched therapy after comprehensive genomic profiling (CGP) tests. However, the clinical utility of CGP tests has not been assessed in clinical practice. We assessed the clinical utility of CGP tests for advanced or meta...

Descripción completa

Detalles Bibliográficos
Autores principales: Ida, Hanae, Koyama, Takafumi, Mizuno, Takaaki, Sunami, Kuniko, Kubo, Takashi, Sudo, Kazuki, Tao, Kayoko, Hirata, Makoto, Yonemori, Kan, Kato, Ken, Okusaka, Takuji, Ohe, Yuichiro, Matsui, Yoshiyuki, Yamazaki, Naoya, Ogawa, Chitose, Kawai, Akira, Narita, Yoshitaka, Esaki, Minoru, Yamamoto, Noboru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
ORIGINAL ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746060/
https://www.ncbi.nlm.nih.gov/pubmed/36106376
http://dx.doi.org/10.1111/cas.15586

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746060/
https://www.ncbi.nlm.nih.gov/pubmed/36106376
http://dx.doi.org/10.1111/cas.15586

Ejemplares similares